You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Mineralocorticoid Receptor antibody [H3122] (ab41912)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Mineralocorticoid Receptor antibody [H3122]
See all Mineralocorticoid Receptor products (5) ...

Description

Mouse monoclonal [H3122] to Mineralocorticoid Receptor

Specificity

In immunohistochemistry this antibody gives good staining in colon and kidney tissue. However, it has not been possible to detect endogenous expression by Western; as positive control a mouse cell line transfected with cDNA was used for this application.

Tested applications

ELISA, IP, IHC-P, WB, Flow Cyt, ICC/IFmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Predicted to work with

Monkey, Marmoset (common)

Immunogen

Baculovirus-expressed recombinant fragment: ETKGYHSLPE GLDMERRWGQ VSQAVERSSL GPTERTDENN YMEIVNVSCV SGAIPNNSTQ GSSKEKQELL PCLQQDNNRP GILTSDIKTE LESKELSA, corresponding to amino acids 2-99 of Human Mineralocorticoid Receptor.

ETKGYHSLPE GLDMERRWGQ VSQAVERSSL GPTERTDENN YMEIVNVSCV SGAIPNNSTQ GSSKEKQELL PCLQQDNNRP GILTSDIKTE LESKELSA

Positive control

IHC: Human and rat large intestine epithelial cells. WB: COS-7 cell lysate transfected with cDNA

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Physiological Saline. Preservative: 0.1% Sodium Azide

Concentration

Concentration information loading...

Purification notes

Purified from ascites after inoculation with hybridoma of mouse myeloma cells via ammonium sulfate fractionation.

Clonality

Monoclonal

Clone number

H3122

Isotype

IgG2a

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody [H3122] (ab41912)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody [H3122] (ab41912) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence-Mineralocorticoid Receptor antibody [H3122](ab41912)Immunocytochemistry/ Immunofluorescence-Mineralocorticoid Receptor antibody [H3122](ab41912) image (enlarge)

  • Flow Cytometry - Mineralocorticoid Receptor antibody [H3122] (ab41912)Flow Cytometry - Mineralocorticoid Receptor antibody [H3122] (ab41912) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab41912 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Receptor for both mineralocorticoids (MC) such as aldosterone and glucocorticoids (GC) such as corticosterone or cortisol. Binds to mineralocorticoid response elements (MRE) and transactivates target genes. The effect of MC is to increase ion and water transport and thus raise extracellular fluid volume and blood pressure and lower potassium levels.

Tissue specificity

Ubiquitous. Highly expressed in distal tubules, convoluted tubules and cortical collecting duct in kidney, and in sweat glands. Detected at lower levels in cardiomyocytes, in epidermis and in colon enterocytes.

Involvement in disease

Defects in NR3C2 are a cause of autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735]. PHA1 is characterized by urinary salt wasting, resulting from target organ unresponsiveness to mineralocorticoids. There are 2 forms of PHA1: the autosomal dominant form that is mild, and the recessive form which is more severe and due to defects in any of the epithelial sodium channel subunits. In AD-PHA1 the target organ defect is confined to kidney. Clinical expression can vary from asymptomatic to moderate. It may be severe at birth, but symptoms remit with age. Familial and sporadic cases have been reported.
Defects in NR3C2 are a cause of early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115]. Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion.

Sequence similarities

Belongs to the nuclear hormone receptor family. NR3 subfamily.
Contains 1 nuclear receptor DNA-binding domain.

Domain

Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.

Post-translational
modifications

Phosphorylated.

Cellular localization

Cytoplasm. Nucleus. Endoplasmic reticulum membrane. Cytoplasmic and nuclear in the absence of ligand; nuclear after ligand-binding. When bound to HSD11B2, it is found associated with the endoplasmic reticulum membrane.

Target information above from: UniProt accessionP08235 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Aldosterone receptor antibody
  • MCR antibody
  • MCR_HUMAN antibody
  • MGC133092 antibody
  • Mineralocorticoid receptor antibody
  • MLR antibody
  • MR antibody
  • NR3 C2 antibody
  • NR3C2 antibody
  • NR3C2 protein antibody
  • Nuclear receptor subfamily 3 group C member 2 antibody
see all

Anti-Mineralocorticoid Receptor antibody [H3122] images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody [H3122] (ab41912)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Mineralocorticoid Receptor antibody [H3122] (ab41912)

ab41912 staining Mineralocorticoid Receptor in human large intestine paraffin section (20-40ug/mL) by Immunohistochemistry, formalin-fixed paraffin embedded sections.

  Immunocytochemistry/ Immunofluorescence-Mineralocorticoid Receptor antibody [H3122](ab41912)

Immunocytochemistry/ Immunofluorescence-Mineralocorticoid Receptor antibody [H3122](ab41912)

ICC/IF image of ab41912 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab41912, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  Flow Cytometry - Mineralocorticoid Receptor antibody [H3122] (ab41912)

Flow Cytometry - Mineralocorticoid Receptor antibody [H3122] (ab41912)

ab41912 used in Flow Cytometry.

Human peripheral blood leukocyte cells were fixed with paraformaldehyde, permeabilized with saponin and then stained with ab41912 (which had been directly conjugated to Alexa Fluor 647), used at a 1/50 dilution. Gated on CD3+ lymphocytes (T cells).

Image courtesy of Luciana Besedovsky by Abreview.

See Abreview

References for Anti-Mineralocorticoid Receptor antibody [H3122] (ab41912)

This product has been referenced in:

  • Fraccarollo Det al. Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123:400-8 (2011). WB; Mouse.Read more (PubMed: 21242479) »
  • López-Andrés Net al. Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes. Endocrinology 149:4970-8 (2008).Read more (PubMed: 18566129) »

See all 2 publications for this product

Publishing research using ab41912? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"